Last fall, we asked the question on our other blogWill Invokana Injury Cases Be Centralized? At that time, a growing number of injured patients had filed lawsuits in Federal Courts. Our firm has been investigating potential Invokana injury claims for some time. For background information on the drug Invokana and its associated injuries, you can read more on the Hot Topics section of our law firm website.

Since our posting, a number of events have occurred. First, the U.S. Judicial Panel on Multidistrict Litigation (JPML) consolidated all Federal Court cases before Judge Brian Martinotti in the U.S. District Court for the District of New Jersey. In January, Judge Martinotti entered an initial case management Order appointing a Federal Magistrate Judge to preside over discovery matters. In that Order, the Judge also indicated a special master or mediator would be appointed early in the case to explore potential settlements. At the end of January, Judge Martinotti entered another Order appointing attorneys to leadership roles on behalf of injured plaintiffs.

In addition to addressing important issues such as discovery procedures, potential settlement negotiations and attorney leadership roles, the Judge has also announced a “Science Day” for July 19, 2017. At that time, the parties will make presentations (in a non-adversarial setting) to educate the court concerning the link between Invokana and reports of injuries such as diabetic ketoacidosis, kidney failure and heart attacks.

The Blackwell Law Firm website and blogs contain several articles about Invokana and the other drugs in its class. These drugs have been associated with serious personal injuries and even deaths. We expect the number of claims involving Invokana injury to increase. You can read our reports and posts here:

If you are an Alabama consumer who suffered injury after taking Invokana or one of its related drugs, we would be happy to answer your questions. Consultations are always free and confidential.